Cargando…

Immunotherapy as sensitizer for local radiotherapy

The purpose of this report was to systematically review the radiation enhancement factor (REF) effects of immunotherapy on radiotherapy (RT) to the local tumor in comparison with other traditional radiation sensitizers such as cisplatin. PubMed and Medline databases were searched until February 2019...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vanneste, Ben G.L., Van Limbergen, Evert J, Dubois, Ludwig, Samarska, Iryna V., Wieten, L., Aarts, M. J.B., Marcelissen, T., De Ruysscher, Dirk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605354/ https://www.ncbi.nlm.nih.gov/pubmed/33194319 http://dx.doi.org/10.1080/2162402X.2020.1832760

Ejemplares similares

An overview of the published and running randomized phase 3 clinical results of radiotherapy in combination with immunotherapy
por: Vanneste, Ben G. L., et al.
Publicado: (2021)

Is prostate cancer radiotherapy using implantable rectum spacers safe and effective in inflammatory bowel disease patients?
por: Vanneste, Ben G.L., et al.
Publicado: (2021)

Combining radiotherapy with immunotherapy: the past, the present and the future
por: Van Limbergen, Evert J, et al.
Publicado: (2017)

Focal salvage high-dose-rate brachytherapy with implantable rectum spacer for locally recurrent prostate cancer after initial low-dose-rate with grade 3 rectal toxicity
por: Opbroek, Thirza, et al.
Publicado: (2023)

Evaluation of hyaluronic acid gel dissolution with hyaluronidase in an in-vitro prostate cancer model
por: Vanneste, Ben G.L., et al.
Publicado: (2022)

Radiation for Oligometastatic Lung Cancer in the Era of Immunotherapy: What Do We (Need to) Know?
por: Peeters, Stephanie T. H., et al.
Publicado: (2021)

A biodegradable rectal balloon implant to protect the rectum during prostate cancer radiotherapy for a patient with active Crohn’s disease
por: Vanneste, Ben G.L., et al.
Publicado: (2018)

Ano-rectal wall dose-surface maps localize the dosimetric benefit of hydrogel rectum spacers in prostate cancer radiotherapy
por: Vanneste, Ben G.L., et al.
Publicado: (2018)

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial
por: Lieverse, Relinde I. Y., et al.
Publicado: (2020)

A scoping review of small animal image-guided radiotherapy research: Advances, impact and future opportunities in translational radiobiology
por: Brown, Kathryn H., et al.
Publicado: (2022)

Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making
por: Ankolekar, Anshu, et al.
Publicado: (2019)

Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?
por: Vanneste, Ben G. L., et al.
Publicado: (2016)

The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses
por: Rekers, Nicolle H., et al.
Publicado: (2018)

Modeling-Based Decision Support System for Radical Prostatectomy Versus External Beam Radiotherapy for Prostate Cancer Incorporating an In Silico Clinical Trial and a Cost–Utility Study
por: van Wijk, Yvonka, et al.
Publicado: (2021)

Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy
por: Marcus, Damiënne, et al.
Publicado: (2021)

Chronic radiation proctitis: tricks to prevent and treat
por: Vanneste, Ben G. L., et al.
Publicado: (2015)

Biomarkers of Radiotherapy-Induced Immunogenic Cell Death
por: Vaes, Rianne D. W., et al.
Publicado: (2021)

Histopathologic and clinical comparison of recurrent and non-recurrent urethral stricture disease treated by reconstructive surgery
por: Samarska, Iryna V., et al.
Publicado: (2021)

Prophylactic cranial irradiation (PCI) in locally advanced non-small cell lung cancer: time for hope?
por: De Ruysscher, Dirk K., et al.
Publicado: (2018)

Proceedings: BCG immunotherapy: its interest in association with radiotherapy in the treatment of Lewis tumour in mice.
por: Dubois, J. B., et al.
Publicado: (1975)

Rapid Decline of Follicular Lymphoma-Associated Chylothorax after Low Dose Radiotherapy to Retroperitoneal Lymphoma Localization
por: Van De Voorde, Lien, et al.
Publicado: (2014)

Hyperprogression under immunotherapy: a new form of immunotherapy response?—a narrative literature review
por: Lin, Miaozhen, et al.
Publicado: (2021)

Human fibronectin extra domain B as a biomarker for targeted therapy in cancer
por: Lieverse, Relinde I. Y., et al.
Publicado: (2020)

Reactivation of BK Polyomavirus in Urine Cytology Is Not Associated with Urothelial Cell Carcinoma
por: Klufah, Faisal, et al.
Publicado: (2020)

Accuracy of deformable image registration for contour propagation in adaptive lung radiotherapy
por: Hardcastle, Nicholas, et al.
Publicado: (2013)

Prediction models for brachytherapy-induced rectal toxicity in patients with locally advanced pelvic cancers: a systematic review
por: Tohidinezhad, Fariba, et al.
Publicado: (2022)

How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review
por: Remon, Jordi, et al.
Publicado: (2021)

Evolving target volume concepts in locally advanced non-small cell lung cancer
por: Nestle, Ursula, et al.
Publicado: (2021)

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity
por: Franco, Nicola Rares, et al.
Publicado: (2021)

The confluence of radiotherapy and immunotherapy
por: Burnette, Byron, et al.
Publicado: (2012)

Radiotherapy and Immunotherapy in Lung Cancer
por: Hsieh, Kristin, et al.
Publicado: (2023)

Short Communication: Management of patients with extensive-stage small-cell lung cancer treated with radiotherapy: A survey of practice
por: Haslett, Kate, et al.
Publicado: (2018)

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
por: Colton, Madyson, et al.
Publicado: (2020)

Immunotherapy in small cell lung cancer: one step at a time: a narrative review
por: Dumoulin, Daphne W., et al.
Publicado: (2021)

Combining Radiotherapy and Immunotherapy in Head and Neck Cancer
por: Runnels, Juliana, et al.
Publicado: (2023)

AB004. Radiotherapy for thymic epithelial tumors: what is the optimal dose?—a systematic review
por: Angrisani, Antonio, et al.
Publicado: (2022)

Decision Support Systems in Prostate Cancer Treatment: An Overview
por: van Wijk, Y., et al.
Publicado: (2019)

AB003. Benefits of proton radiotherapy in thymic epithelial tumors using the model-based approach
por: Peeters, Stephanie T. H., et al.
Publicado: (2022)

Hypofractionated radiotherapy combined with targeted therapy or immunotherapy: Dutch survey on current practice, knowledge and challenges
por: van Aken, Evert S.M., et al.
Publicado: (2022)

A Rare Case of Angioimmunoblastic T-Cell Lymphoma with Epstein-Barr Virus-Negative Reed-Sternberg-Like B-Cells, Chylous Ascites, and Chylothorax
por: Willemsen, Mathijs, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_aq21qgoac4b4jptbbpmaoggvco